Aug 17, 2024, 19:56
Oncotype DX Colon Recurrence Score in stage II colon cancer, summary by Erman Akkus
Erman Akkus, Medical Oncology Fellow a post on X:
“Oncotype DX Colon Recurrence Score in stage II colon cancer at ESMO Open.
- Real-word data, 938 patients
- Higher score ->worse clinicopathologial factors, higher treatment
- Score is prognostic
- In high score (41-100), ChT vs observation, colon cancer specific survival, p=0.035“
Authors: B. Brenner, K. Shulman, A. Hubert, S. Man, R. Geva, I. Ben-Aharon, S. Fennig, M. Mishaeli, N. Yarom, G. Bar-Sela, R. Brenner, A. Shai, F.L. Baehner, C. Russell, L. Soussan-Gutman ,H. Voet, A. Bareket-Samish, and N. Liebermann.
Source: Erman Akkus/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 00:19
Nov 14, 2024, 00:02
Nov 13, 2024, 23:57
Nov 13, 2024, 23:54
Nov 13, 2024, 23:48